Diagnosis, management and outcome of Candida endocarditis

Clinical Microbiology and Infection

Volumn 18, Issue 4, 2012, Pages

  Lefort, A ^a   Chartier, L ^b   Sendid, B ^c   Wolff, M ^a   Mainardi, J L ^a,d,e   Podglajen, I ^a   Desnos Ollivier, M ^b,f   Fontanet, A ^b,g   Bretagne, S ^b,f,h   Lortholary, O ^a,b,f  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSTITUT PASTEUR   (France)

^c UNIV LILLE   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e INSERM   (France)

^f CNRS URA3012   (France)

^g Bioinformatique et Chimie Moléculaire   (France)

^h HENRI MONDOR HOSPITAL   (France)

Author keywords

Antibody detection; Antigen detection; Candida; Endocarditis; Molecular tools

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANTIBODY; BETA 1,3 GLUCAN; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; FUNGAL DNA; MANNAN; MANNAN ANTIBODY; UNCLASSIFIED DRUG; VORICONAZOLE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIFUNGAL SUSCEPTIBILITY; ANTIGEN DETECTION; ARTICLE; BLOOD CULTURE; CANDIDA; CANDIDA ALBICANS; CANDIDA ENDOCARDITIS; CANDIDA GLABRATA; CANDIDA ORTHOPSILOSIS; CANDIDA PARAPSILOSIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HOSPITAL DISCHARGE; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ABUSE; KLUYVEROMYCES MARXIANUS; MALE; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; PICHIA ANOMALA; PICHIA GUILLIERMONDII; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SCHOOL CHILD;

CANDIDA;

EID: 84858703404     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2012.03764.x     Document Type: Article

References (40)

1. Baddley JW, Benjamin DK Jr, Patel M et al. Candida infective endocarditis. Eur J Clin Microbiol Infect Dis 2008; 27: 519-529.
2. Falcone M, Barzaghi N, Carosi G et al. Candida infective endocarditis: report of 15 cases from a prospective multicenter study. Medicine (Baltimore) 2009; 88: 160-168.
3. Murdoch DR, Corey GR, Hoen B et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 2009; 169: 463-473.
4. Chopra T, Bhargava A, Kumar S et al. Candida kefyr endocarditis in a patient with hypertrophic obstructive cardiomyopathy. Am J Med Sci 2010; 339: 188-189.
5. Ellis ME, Al-Abdely H, Sandridge A, Greer W, Ventura W. Fungal endocarditis: evidence in the world literature, 1965-1995. Clin Infect Dis 2001; 32: 50-62.
6. Pierrotti LC, Baddour LM. Fungal endocarditis, 1995-2000. Chest 2002; 122: 302-310.
7. Wang JH, Liu YC, Lee SS. Candida endocarditis following percutaneous transluminal coronary angioplasty. Clin Infect Dis 1998; 26: 205-206.
8. Pappas PG, Kauffman CA, Andes D et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48: 503-535.
9. Li JS, Sexton DJ, Mick N et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30: 633-638.
10. Ascioglu S, Rex JH, de Pauw B et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7-14.
11. Benito N, Miro JM, de Lazzari E et al. Health care-associated native valve endocarditis: importance of non-nosocomial acquisition. Ann Intern Med 2009; 150: 586-594.
12. Egeblad H, Wennevold A, Berning J, Lauridsen P. Mitral valve replacement in infective endocarditis as prophylaxis against embolism. Identification of patients at risk by 2-dimensional echocardiography. Eur J Cardiol 1979; 10: 369-373.
13. Daniel WG, Mugge A, Martin RP et al. Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography. N Engl J Med 1991; 324: 795-800.
14. Klug D, Balde M, Pavin D et al. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation 2007; 116: 1349-1355.
15. Subcommittee of Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST). EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts. Clin Microbiol Infect 2008; 14: 398-405.
16. Desnos-Ollivier M, Bretagne S, Raoux D, Hoinard D, Dromer F, Dannaoui E. Mutations in the fks1 gene in Candida albicans, C. tropicalis, and C. krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the European Committee on Antibiotic Susceptibility Testing. Antimicrob Agents Chemother 2008; 52: 3092-3098.
17. Dannaoui E, Lortholary O, Raoux D et al. Comparative in vitro activities of caspofungin and micafungin, determined using the method of the European Committee on Antimicrobial Susceptibility Testing, against yeast isolates obtained in France in 2005-2006. Antimicrob Agents Chemother 2008; 52: 778-781.
18. Lortholary O, Dannaoui E, Raoux D et al. In vitro susceptibility to posaconazole of 1903 yeast isolates recovered in France from 2003 to 2006 and tested by the method of the European committee on antimicrobial susceptibility testing. Antimicrob Agents Chemother 2007; 51: 3378-3380.
19. EUCAST Technical Note on fluconazole. Clin Microbiol Infect 2008; 14: 193-195.
20. EUCAST Technical Note on voriconazole. Clin Microbiol Infect 2008; 14: 985-987.
21. Desnos-Ollivier M, Bretagne S, Bernede C et al. Clonal population of flucytosine-resistant Candida tropicalis from blood cultures, Paris, France. Emerg Infect Dis 2008; 14: 557-565.
22. Sendid B, Caillot D, Baccouch-Humbert B et al. Contribution of the Platelia Candida-specific antibody and antigen tests to early diagnosis of systemic Candida tropicalis infection in neutropenic adults. J Clin Microbiol 2003; 41: 4551-4558.
23. Playford EG, Kong F, Sun Y, Wang H, Halliday C, Sorrell TC. Simultaneous detection and identification of Candida, Aspergillus, and Cryptococcus species by reverse line blot hybridization. J Clin Microbiol 2006; 44: 876-880.
24. White TJ, Burns TD, Lee SB, Taylor JW. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. In: White TJ, ed. PCR protocols. San Diego, CA: Academic Press, 1990; 315-322.
25. Donal E, Abgueguen P, Coisne D et al. Echocardiographic features of Candida species endocarditis: 12 cases and a review of published reports. Heart 2001; 86: 179-182.
26. Melgar GR, Nasser RM, Gordon SM, Lytle BW, Keys TF, Longworth DL. Fungal prosthetic valve endocarditis in 16 patients. An 11-year experience in a tertiary care hospital. Medicine (Baltimore) 1997; 76: 94-103.
27. Steinbach WJ, Perfect JR, Cabell CH et al. A meta-analysis of medical versus surgical therapy for Candida endocarditis. J Infect 2005; 51: 230-247.
28. Kuhn DM, George T, Chandra J, Mukherjee PK, Ghannoum MA. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 2002; 46: 1773-1780.
29. Leroy O, Gangneux JP, Montravers P et al. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Crit Care Med 2009; 37: 1612-1618.
30. Horn DL, Neofytos D, Anaissie EJ et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis 2009; 48: 1695-1703.
31. Dizbay M, Fidan I, Kalkanci A et al. High incidence of Candida parapsilosis candidaemia in non-neutropenic critically ill patients: epidemiology and antifungal susceptibility. Scand J Infect Dis 2010; 42: 114-120.
32. Sipsas NV, Lewis RE, Tarrand J et al. Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection. Cancer 2009; 115: 4745-4752.
33. Grijalva M, Horvath R, Dendis M, Erny J, Benedik J. Molecular diagnosis of culture negative infective endocarditis: clinical validation in a group of surgically treated patients. Heart 2003; 89: 263-268.
34. Vollmer T, Stormer M, Kleesiek K, Dreier J. Evaluation of novel broad-range real-time PCR assay for rapid detection of human pathogenic fungi in various clinical specimens. J Clin Microbiol 2008; 46: 1919-1926.
35. Fernandez AL, Varela E, Martinez L et al. Evaluation of a multiplex real-time PCR assay for detecting pathogens in cardiac valve tissue in patients with endocarditis. Rev Esp Cardiol 2010; 63: 1205-1208.
36. Casalta JP, Gouriet F, Roux V, Thuny F, Habib G, Raoult D. Evaluation of the LightCycler SeptiFast test in the rapid etiologic diagnostic of infectious endocarditis. Eur J Clin Microbiol Infect Dis 2009; 28: 569-573.
37. Wallet F, Nseir S, Baumann L et al. Preliminary clinical study using a multiplex real-time PCR test for the detection of bacterial and fungal DNA directly in blood. Clin Microbiol Infect 2010; 16: 774-779.
38. Mikulska M, Calandra T, Sanguinetti M, Poulain D, Viscoli C, Third European Conference On Infections In Leukemia Group T. The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia. Crit Care 2010; 14: R222.
39. Mikulska M, Furfaro E, Del Bono V et al. Persistence of positive (1, 3)-beta-D-glucan test after clearance of candidemia in HSCT recipients. Clin Vaccine Immunol 2011; 18: 518-519.
40. Duval X, Iung B, Klein I et al. Effect of early cerebral magnetic resonance imaging on clinical decisions in infective endocarditis: a prospective study. Ann Intern Med 2010; 152: 497-504.